Empower, educate and execute: Oral-systemic care in action

With periodontitis now recognized as a biological driver of cardiovascular disease, cancer, diabetes, kidney disease, and even dementia, dental professionals hold untapped power to impact the nation’s chronic disease crisis.

According to the CDC, the five most prevalent chronic noncommunicable diseases in the US are cardiovascular disease, cancer, diabetes, chronic respiratory disease, and chronic kidney disease. These collectively affect six in 10 US adults and account for $4.1 trillion in annual health-care expenditure.1  

Periodontitis as the link 

What most physicians have not yet fully integrated into practice, and what most dentists have not yet fully leveraged, is that every one of those conditions shares a mechanistic, bidirectional relationship with a disease they diagnose and treat every single day: periodontitis. 

This is not a correlation or coincidence; it is established biology.  Empowerment is intentional. As the practice leader, you can guide your team to recognize periodontitis as both a risk factor for and a condition exacerbated by noncommunicable diseases, demonstrating its bidirectional impact.2 

The oral cavity is integral to systemic health. Inflammation from untreated periodontal disease extends beyond the mouth, worsening the chronic conditions your patients already manage. As a leader, you must ensure your practice acts on this knowledge. 

A changing patient landscape 

Gen-Xers, millennials, and Gen Z patients are sitting in your chairs tracking their resting heart rate, HRV, sleep stages, and blood glucose using wearable devices. They are active participants in their own biology, and they are looking for providers who meet them there. 

 iHealthcare Analyst estimates that the global market for preventive health-care technologies and services will reach $532 billion by 2034.3 Conversations will shift from "does my insurance cover this?" to "how will this improve my overall health span and protect my quality of life?" Will you and your team have the protocols in place and the shared language ready to answer those questions?  

Implementing systemic health protocols can improve patient outcomes and support practice growth. Transitioning from a traditional dental model to an oral health wellness center will set your practice apart. The hygiene operatory is a valuable clinical asset for delivering comprehensive, oral-systemic care. This shift may also encourage your team to make better personal health choices. 

Step one: Educate 

The science is not new. What is new is the volume, the precision, and the clinical urgency with which it is now being delivered.  Education  means building a team capable of translating the biology; team members need to understand the mechanism well enough to speak to it clearly, consistently, and confidently at the chair. These are the five connections that form the biological foundation of oral-systemic care. 

Cardiovascular disease and hypertension: Periodontal disease is independently associated with higher rates of coronary disease, stroke, and atherosclerosis across multiple large epidemiologic studies, with systemic inflammation serving as the primary biological link. Periodontal pathogens and their genetic material have been identified in atherosclerotic plaques, while individuals with periodontal disease consistently demonstrate elevated circulating inflammatory markers, including C-reactive protein, interleukins, and tumor necrosis factor, all of which are also implicated in the development and progression of atherosclerosis. Bacteremia allows those pathogens direct access to vascular tissues. 

The 2025 American Heart Association Scientific Statement confirmed an association between periodontal disease and atherosclerotic cardiovascular disease.4  A meta-analysis of 39 cohort studies representing 4.3 million individualsfound independent associations with coronary heart disease, myocardial infarction, stroke, and all-cause mortality.

A systematic review and meta-analysis drawing from 81 studies also found that diagnoses of moderate-to-severe periodontitis were independently associated with hypertension, with patients with periodontitis exhibiting significantly higher systolic and diastolic blood pressure values compared to those without periodontal disease.6 

Cancer: A nationwide population-based cohort study confirmed that periodontal disease is associated with increased risk of cancer across multiple organ sites after controlling for confounders.7 A systematic review and meta-analysis of 19 studies encompassing 16.6 million participants found a 31% increased risk of overall gastrointestinal cancers, a 39% increased risk of esophageal cancer, and a 13% increased risk of gastric cancer in patients with periodontal disease.8 The mechanism is microbial: periodontal pathogens drive chronic dysbiosis, immune evasion, and direct epigenetic damage to epithelial tissue.9 

Diabetes: The diabetes connection is mechanistically established and bidirectional. A systematic review and meta-analysis of cohort studies found a 24% increased incidence of periodontitis in diabetic patients and a 26% increased relative risk of developing diabetes with active periodontitis.10 A 2025 systematic review confirmed that periodontal therapy improves glycemic parameters, while noting that the overall evidence remains heterogeneous.11 A patient whose HbA1c is uncontrolled and whose periodontal disease is untreated is caught in a biological feedback loop that neither their endocrinologist nor their primary care physician is positioned to interrupt; your dental hygienist is. 

Chronic kidney disease: An umbrella review confirmed 2.5 times higher odds of periodontitis with chronic kidney disease (CKD) and twice the likelihood of developing CKD in patients with active periodontitis.12 Periodontitis was also independently associated with increased mortality risk in CKD patients.13 CKD affects 37 million US adults, most of whom have dentists.14 Are nephrologists asking about their gums? 

Dementia and Alzheimer's disease: A 2025 systematic review and meta-analysis found periodontitis is associated with dementia at an odds ratio of 2.26, and severe periodontitis is linked to a 6.87-fold higher risk of Alzheimer's disease.15 These findings show there are ways to help patients identify risk factors that may contribute to these outcomes later in life, especially for patients already in your care. 

Step 2: Execute 

Knowledge alone does not drive change; applying it in clinical practice does. The following actions will help your practice move from awareness to implementation. 

Rebuild your medical history intake: Identify systemic risks by including fields for cardiovascular diagnoses, current HbA1c values, kidney function, respiratory diagnoses, cancer history, and medications such as antihypertensives and immunosuppressants. Each systemic condition presents an opportunity to discuss periodontal risk. Ask if there is a family history of the medical conditions listed in your form.  Make intake your first clinical intervention and systematize it using platforms that integrate with your practice management system. 

Stage and grade every periodontal patient as a systemic triage tool: The 2017 AAP/EFP classification system is not administrative paperwork. It is a biological risk stratification tool. Staging quantifies tissue destruction. Grading indicates how quickly the disease is progressing and whether systemic conditions are modifying it. A grade C patient with uncontrolled diabetes is not a routine recall patient. They are a medically complex patient, and their treatment plan must reflect that complexity.16 

Train your team to speak one clinical language: Your hygienists, assistants, and front -desk staff need a clear, plain-language explanation of the oral-systemic connection, a consistent script for chairside introductions, and the confidence to deliver it effectively. Invest in team training, role-play conversations, and standardize language across all operatories. When your team communicates consistently, patients perceive the information as fact. 

Guided Biofilm Therapy offers a biology-led protocol: The treatment protocols referenced in this article that demonstrate positive oral-systemic outcomes include traditional non-surgical periodontal scaling and root planing (SRP). Guided Biofilm Therapy (GBT), developed by EMS, introduces an eight-step biofilm-management protocol that utilizes erythritol airflowing followed by targeted piezoceramic instrumentation, representing a minimally invasive clinical approach to the comprehensive management of biofilm, calculus, and inflammation. A 2024 randomized controlled trial reported pocket-closure rates with GBT comparable to those achieved with conventional SRP, as well as reduced treatment time.17 GBT's focus on comprehensive biofilm disruption as a primary clinical endpoint, rather than calculus removal alone, addresses the etiologic driver of periodontal inflammation at its source. Pathogenic biofilm induces the release of IL-1β, IL-6, TNF-alpha, and bacterial lipopolysaccharides (LPS), which enter the bloodstream and initiate endothelial dysfunction, oxidative stress, and progressive atherogenesis.18,19 Enhancing the thoroughness and consistency of biofilm management, therefore, can offer biological plausibility for reducing the systemic inflammatory cascade.  

Establish physician referral and comanagement pathways: Identify two or three primary care physicians, endocrinologists, and cardiologists in your area who are open to bidirectional referrals. Prepare a one-page clinical summary to share when patients present with uncontrolled systemic disease and active periodontitis. Position your practice as the oral medicine partner physicians need. This approach makes the hygiene operatory a key strategic asset. 

The decision is yours 

Your RDH is more than a tooth cleaner. Dentists and leaders must empower and educate them to serve as frontline systemic health providers, often seeing medically complex patients more frequently than primary care physicians. The RDH should document bleeding on probing for patients whose cardiologists may not be aware of oral infections and chart pocket depths for those whose endocrinologists have not addressed oral inflammation. 

Provide your team with effective language, support their education with evidence, and implement protocols collaboratively. Many of your current patients are managing diabetes, hypertension, kidney disease, and cancer. Some may experience a myocardial infarction or stroke in the next five years, but timely intervention from your team could prevent these outcomes. You can be the one to make that difference. 

This is not about brand expansion or adding a service line. It is about choosing to make your practice part of the solution to the chronic disease crisis affecting health care. You have access, science, and a capable team. Now put them to use. 


Editor's note: This article appeared in the May 2026 print edition of Dental Economics magazine. Dentists in North America are eligible for a complimentary print subscription. Sign up here.

References:

  1. Carney TJ, Wiltz JL, Davis K, et al. Advancing chronic disease practice through the CDC data modernization initiative. Prev Chronic Dis. 2023;20:230120. doi:10.5888/pcd20.230120

  2. Rodríguez-Medina C, Amaya Sánchez S, Contreras, A, et al. Grading the strength and certainty of the scientific evidence of the bidirectional association between periodontitis and noncommunicable diseases: an umbrella review. Evid Based Dent. 2025;26(3):147. doi:10.1038/s41432-025-01132-9 

  1. Global preventive healthcare market $532 billion by 2034. iHealthcareAnalysis. August 21, 2025. https://www.ihealthcareanalyst.com/government-initiatives-public-awareness-propel-preventive-health-care-technologies-services-market/ 

  1. Tran AH, Zaidi AH, Bolger AF, et al. Periodontal disease and atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2026;10;153(6):e73-e88. doi:10.1161/CIR.0000000000001390 

  1. Orlandi M, Guzik TJ, Hingorani AD, et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc Res. 2020;1;116(1):28-39. doi:10.1093/cvr/cvz201 

  1. Muñoz Aguilera E, Suvan J, Buti J, et al. Periodontitis is associated with hypertension: a systematic review and meta-analysis. Cardiovasc Res. 2020;116(1):28-39. doi:10.1093/cvr/cvz201 

  1. Kim EH, Nam S, Park CH, et al. Periodontal disease and cancer risk: a nationwide population-based cohort study. Front Oncol. 2022;23;12:901098. doi:10.3389/fonc.2022.901098 

  1. Wang T, Cao H, Ma S, et al. Periodontal disease and gastric and colorectal cancers: mechanisms and therapeutic perspectives. Front Cell Infect Microbiol. 2025;15:1699738. doi:10.3389/fcimb.2025.1699738 

  1. Baima G, Minoli M, Michaud DS, et al. Periodontitis and risk of cancer: mechanistic evidence. Periodontol 2000. 2024;96(1):83-94. doi:10.1111/prd.12540 

  1.  Stöhr J, Barbaresko J, Neuenschwander M, et al. Bidirectional association between periodontal disease and diabetes mellitus: a systematic review and meta-analysis of cohort studies. Sci Rep. 2021;11(1):13686. doi:10.1038/s41598-021-93062-6 

  1. Graves DT, Levine MA, Aldosary S, et al. Understanding the periodontitis-diabetes linkage: mechanisms and evidence. J Dent Res. 2026;105(1):21-30. doi:10.1177/00220345251388340 

  1. He I, Poirier B, Jensen E, et al. Demystifying the connection between periodontal disease and chronic kidney diseasean umbrella review. J Periodontal Res. 2023;58(5):874-892. doi:10.1111/jre.13161 

  1. Wu H, Wang S, Wei Z. Periodontitis and risk of mortality in patients with chronic kidney disease: a systematic review with meta-analysis. J Periodontal Res. 2024;59(5):868-876. doi:10.1111/jre.13255 

  1. Chronic kidney disease in the United States. Centers for Disease Control and Prevention. March 31, 2026. https://www.cdc.gov/kidney-disease/php/data-research/index.html 

  1. Kim DH, Han GS. Periodontitis as a risk factor for dementia: a systematic review and meta-analysis. J Evid Based Dent Pract. 2025;25(2):102094. doi:10.1016/j.jebdp.2025.102094 

  1. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. 2018;89 Suppl 1:S159-S172. doi:10.1002/JPER.18-0006. 

  1. Cyris M, Festerling J, Kahl M, Springer C, Dörfer CE, Graetz C. Guided biofilm therapy versus conventional protocol-clinical outcomes in non-surgical periodontal therapy. BMC Oral Health. 2024;24(1):1105. doi:10.1186/s12903-024-04898-z 

  1. Isola G, Santonocito S, Lupi SM, et al. Periodontal health and disease in the context of systemic diseases. Mediators Inflamm. 2023;13;2023:9720947. doi:10.1155/2023/9720947

  2. Bida FC, Curca FR, Lupusoru RV, et al. The systemic link between oral health and cardiovascular disease: contemporary evidence, mechanisms, and risk factor implications. Diseases. 2025;31;13(11):354. doi:10.3390/diseases13110354

About the Author

Melissa A. Obrotka, BA, RDH

Melissa A. Obrotka, BA, RDH

Melissa A. Obrotka, BA, RDH, has over 25 years of clinical experience in prosthodontics and periodontics, with a focus on implant maintenance, nonsurgical therapies, and the connection between oral and systemic wellness. She is the creator of The OPSM Framework™, translating oral-systemic science into real clinical decisions that change patient outcomes. Melissa was honored as a Master Clinician by the ADHA in 2016 and named one of the "Six Dental Hygienists You Want to Know" by Dimensions of Dental Hygiene in 2017.

Sign up for our eNewsletters
Get the latest news and updates